The Neurobiology of Addiction

The Neurobiology of Addiction

5 (1 rating by Goodreads)
Edited by  , Edited by  , Edited by 

List price: US$93.00

Currently unavailable

We can notify you when this item is back in stock

Add to wishlist

AbeBooks may have this title (opens in new window).

Try AbeBooks

Description

In the past two decades, there have been astonishing advances in our understanding of the neurobiological basis and nature of drug addiction. We now know the initial molecular sites of action, at identified receptors, of virtually all of the major drugs of abuse including cocaine, heroin, and amphetamine, as well as legal drugs such as nicotine and alcohol. We also understand the main components of a 'reward system' and its connections to major brain regions involved
in motivation and emotion, such as the amygdala, hippocampus, and prefrontal cortex.

The Neurobiology of Addiction describes the latest advances in our understanding of addiction. It brings together world class researchers to debate the nature and extent of addiction, as well as its causes, consequences, and treatment. The focus of the book is on the brain processes underlying addiction, in terms of neural systems, neurochemical basis, and molecular changes. Several types of addiction are discussed ranging from illicit drugs - cocaine, amphetamine, and heroin to legal drugs
- alcohol and nicotine. In addition, it explores increasingly common behavioural addictions such as gambling and obesity. Included are chapters on vulnerability to addiction, genetic factors, opponent motivational processes, animal models, relapse, cognitive deficits associated with drug abuse, new
pharmacological treatments, and current controversies concerning different neuropsychological theories of addiction. Throughout, it reports on cutting edge research using brain imaging, and state of the art molecular methodology.

The book will make fascinating reading for students and teachers in the field of neuroscience, pharmacology and psychology, as well as experts in the field.
show more

Product details

  • Hardback | 318 pages
  • 177 x 253 x 20mm | 788g
  • Oxford, United Kingdom
  • English
  • 0199562156
  • 9780199562152
  • 1,139,524

Table of contents

Introduction. The neurobiology of drug addiction: new vistas ; Neurobiological mechanisms for opponent motivational processes in addiction ; Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction ; The incentive sensitization theory of addiction: some current issues ; Psychological and neural mechanisms of relapse ; Neurobiology of nicotine dependence ; Cognitive and emotional consequences of binge drinking: role of amygdala and prefrontal cortex ; The neurobiology of pathological gambling and drug addiction: an overview and new findings ; Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology ; Neurogenetic studies of alcohol addiction ; Genetics of addictions: strategies for addressing heterogeneity and polygenicity of substance use disorders ; Positron emission tomography imaging studies of dopamine receptors in primate models of addiction ; Context-induced relapse to drug seeking: a review ; Transcriptional mechanisms of addiction: role of changes in FosB ; Parallel studies of cocaine-related neural and cognitive impairment in humans and monkeys ; Acute effects of cocaine on the neurobiology of cognitive control ; Evidence-based treatments of addiction
show more

About Trevor Robbins

Professor Robbins is Professor of Cognitive Neuroscience and Head of the Department of Experimental Psychology at the University of Cambridge. He is also Director of the Cambridge MRC-Wellcome Trust Behavioural and Clinical Neuroscience Institute (BCNI), the main objective of which is to inter-relate basic and clinical research in psychiatry and neurology for such conditions as Parkinson's, Huntington's, and Alzheimer's diseases, frontal lobe injury, schizophrenia,
depression, drug addiction, and developmental syndromes such as attention deficit/hyperactivity disorder. The BCNI has a particular focus on pharmacological treatments in neuropsychiatry and neurological disorders and how they actually work. Trevor has been President of the European Behavioural
Pharmacology Society (1992-1994) and he won that Society's inaugural Distinguished Achievement Award in 2001. He was also President of the British Association of Psychopharmacology from 1996 to 1997. He a Fellow of the Royal Society

David is currently the Edmond J Safra Professor of Neuropsychopharmacology and Head of the Department of Neuropsychopharmacology and Molecular Imaging at Imperial College London
He received his undergraduate training in medicine at Cambridge and Guy's Hospital, and continued training in neurology to MRCP. After completing his psychiatric training in Oxford, he continued there as a lecturer and then later as a Wellcome Senior Fellow in psychiatry. He then spent two years as Chief of the Section of Clinical Science in the National Institute of Alcohol Abuse and Alcoholism in NIH, Bethesda, USA. On returning to England in 1988 he set up the Psychopharmacology Unit in
Bristol, an interdisciplinary research grouping spanning the departments of Psychiatry and Pharmacology. In December 2008 he joined Imperial College London as the Edmond J Safra Chair in Neuropsychopharmacology to concentrate on development of PET imaging.

Professor Everitt graduated in Zoology and Psychology at Hull University, received a Ph.D. from the University of Birmingham, and undertook post-doctoral research at Birmingham and at the Karolinska Institute in Stockholm, with the eminent neuroanatomists Tomas Hoekfelt and Kjell Fuxe. He was appointed to the Department of Anatomy at the University of Cambridge in 1974, became a Fellow of Downing College in 1976, a tenured University Lecturer and a Director of Studies in Medicine at Downing
in 1979. He has served on several national and international advisory committees and has been President of the British Association for Psychopharmacology, the European Brain and Behaviour Society and the European Behavioural Pharmacology Society. He is a Fellow of the Royal Society (FRS), a Fellow of the
Academy of Medical Sciences (FMedSci), and has been awarded an Honorary D.Sc. by Hull University
show more

Rating details

1 rating
5 out of 5 stars
5 100% (1)
4 0% (0)
3 0% (0)
2 0% (0)
1 0% (0)
Book ratings by Goodreads
Goodreads is the world's largest site for readers with over 50 million reviews. We're featuring millions of their reader ratings on our book pages to help you find your new favourite book. Close X